Blue versus white light for transurethral resection of non-muscle invasive bladder cancer-Reference-Cited by-同舟云学术

Blue versus white light for transurethral resection of non-muscle invasive bladder cancer

Published:2021-12-01 Issue:12 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Maisch Philipp¹²,Koziarz Alex³,Vajgrt Jon⁴,Narayan Vikram⁵,Kim Myung Ha⁶,Dahm Philipp⁷⁸

Affiliation:

1. Department of Urology; University of Ulm; Ulm Germany

2. Department of Urology; Rechts der Isar Medical Center, Technical University of Munich; Munich Germany

3. Faculty of Medicine; University of Toronto; Toronto Canada

4. University of Minnesota Medical School; Minneapolis, MN USA

5. Department of Urology; Emory University; Atlanta Georgia USA

6. Yonsei Wonju Medical Library; Yonsei University Wonju College of Medicine; Wonju Korea, South

7. Urology Section; Minneapolis VA Health Care System; Minneapolis Minnesota USA

8. Department of Urology; University of Minnesota; Minneapolis Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference175 articles.

1. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer;Babjuk;BJU International,2005

2. Fluorescence cystoscopy in the diagnostics and treatment of superficial urinary bladder tumors;Babjuk;Casopis Lékaru Ceských,2005

3. Improved diagnosis and long-term recurrence rate reduction for non-muscle-invasive bladder cancer patients undergoing fluorescent hexylaminolevulinate photodynamic diagnosis;Drăgoescu;Romanian Journal of Morphology and Embryology,2017

4. Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid;Maria;Romanian Journal of Morphology and Embryology,2011

5. Use of hexaminolevulinate improves diagnosis sensitivity and treat ment efficiency of nonmuscle invasive bladder cancer;Maria;European Urology, Supplements,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline: 2024 Amendment;Journal of Urology;2024-04

2. Re: Rakesh Heer, Rebecca Lewis, Thenmalar Vadiveloo, et al. A Randomized Trial of PHOTOdynamic Surgery in Non–muscle-invasive Bladder Cancer. NEJM Evid 2022;1:EVIDoa2200092;European Urology;2024-02

3. Response to letter to the editor on the systematic review “Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer”;World Journal of Urology;2024-01-08

4. The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence;Clinical Genitourinary Cancer;2023-12

5. A cost-consequences and budget impact analysis of blue light-guided cystoscopy with Hexvix in patients diagnosed with non-muscle-invasive bladder cancer in France;Journal of Medical Economics;2023-10-28